Anbio Biotechnology Class A Ordinary Shares
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $4,737 | $2,031 | $5,007 |
Gross Profit | 3,860 | 1,655 | 4,622 |
EBITDA | 2,799 | 3,677 | |
Net Income | 3,038 | 1,302 | 4,148 |
Net Change In Cash | 4,737 | 2,031 | 5,007 |
Cash | 7,766 | 7,766 | 6,278 |
Basic Shares | 43,891 | 43,894 | 43,891 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $8,646 | $8,185 | $6,711 | $23,544 |
Gross Profit | 7,543 | 5,885 | 3,360 | 12,563 |
EBITDA | 5,767 | 1,995 | 2,266 | 10,025 |
EBIT | 1,995 | 2,253 | 10,019 | |
Net Income | 6,403 | 2,372 | 2,253 | 10,011 |
Net Change In Cash | 8,646 | 8,185 | 6,711 | 23,544 |
Free Cash Flow | -6,739 | 2,080 | 898 | 4,448 |
Cash | 7,766 | 11,760 | 9,687 | 7,102 |
Basic Shares | 43,891 | 42,291 | 187,782 | 143,891 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0.09 |
2025-03-31 | -$0.03 |
2024-09-30 | $0.09 |